Parameter | Country | |||||||
---|---|---|---|---|---|---|---|---|
Estonia | Russia | South Africa | Peru | China | Philippines | India | ||
Cost of treatment per month, US$ [source] | ||||||||
 Cost of BR (intensive) | 273 [18] | 149 [22] | 78 [23] | 134 [25] | 95 [37] | |||
 Cost of BR (continuation) | 78 [20;25] | 183 [18] | 71 [22] | 26 [23] | 88 [25] | 40 [37] | ||
Cost of monitoring per month, US$ [source] | ||||||||
 Bedaquiline + BR | Intensive phase | 109 [20] | 122 [19] | 81 [26] | 81 [21] | 63 [23] | 65b | |
Continuation phase | 98 [20] | 94 [19] | 64 [26] | 70 [21] | 55 [23] | 595b | ||
 BR only | Intensive phase | 101 [20] | 100 [19] | 65 [26] | 68 [21] | 60 [23] | 59b | |
Continuation phase | 90 [20] | 72 [19] | 48 [26] | 57 [21] | 52 [23] | 53b | ||
Cost of inpatient and outpatient care, US$ [source] | ||||||||
 Cost of hospitalization for initial MDR-TB per day | 268 [24] | 231 [18] | 84 [26] | 55 [21] | 38 [24] | 20 [24] | 16 [30] | |
 Cost of outpatient care for initial MDR-TB | No. of consultation per month (mean)/unit cost | 1/41 [24] | 1/36 [24] | 1/17 [26] | 1/11 [21] | 1/9 [24] | 1/6 [24] | 1/3 [30] |
No. of TB nurse home visits per month (mean)/unit cost | 28/1 [24] | 28/0 [24] | 28/NA [26] | 28/NA [21] | 28/NA [24] | 28/NA [24] | 28/NA [30] | |
Disability weights (mean) by health state for all countries analyzed | ||||||||
 Active TB | 0.331 [16] | |||||||
 Culture converted TB (first year) | 0.170 [16] | |||||||
 Culture converted TB (subsequent year) | 0.170 [16] | |||||||
 Lost to follow-up | 0.331 (Assumed equal to the active MDR-TB state) | |||||||
 Treatment complete and cured | 0 (Assumed equal to the general population [41]) | |||||||
 Death | 1 |